emergency use authorization
Roche Multiplex SARS-CoV-2, Flu Test Gets FDA Emergency Use Authorization
The Cobas SARS-CoV-2 & Influenza A/B V2 is a real-time RT-PCR assay that is used to detect and differentiate COVID-19 and influenza A/B.
MAWD Laboratories Receives FDA EUA for COVID-19 PCR Test
The MAWD Laboratories SARS-CoV-2 Dual Target by RT-PCR test qualitatively detects SARS-CoV-2 in nasopharyngeal swab specimens.
FDA Grants Emergency Use Authorizations for POC COVID Tests from Tangen Biosciences, SD Biosensor
Tangen's test detects SARS-CoV-2 nucleic acid and runs on the firm's GeneSpark system, while SD Biosensor's lateral flow immunoassay detects the virus's nucleocapsid protein antigen.
3EO Health At-Home Molecular COVID-19 Test Nabs FDA EUA
The 3EO Health test uses nucleic acid amplification technology to detect SARS-CoV-2 RNA in anterior nasal swab samples.
Princeton BioMeditech Gets FDA Emergency Use Authorization for Point-of-Care COVID-19, Flu Test
The company recently received a National Institutes of Health grant for an at-home assay to detect both COVID-19 and influenza A and B.
May 31, 2023
May 26, 2023
BioTeke Nabs FDA EUA for COVID-19 Rapid Antigen Test
Mar 20, 2023